Press release
Parkinson's Disease Psychosis (PDP) Market reaching approximately USD 3.7 billion by 2034
Parkinson's Disease Psychosis (PDP) Market
Historically, PDP management has been challenging because many antipsychotics worsen motor symptoms by interfering with dopamine pathways. However, with the advent of targeted therapies such as pimavanserin and increased awareness of non-motor symptoms, the treatment landscape has expanded. Ongoing innovation, rising PD prevalence, and greater focus on quality-of-life outcomes are fueling growth in the PDP market.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/71916
Market Overview
The global Parkinson's disease psychosis (PDP) market was valued at USD 1.9 billion in 2024 and is projected to grow at a CAGR of 6.8% between 2024 and 2034, reaching approximately USD 3.7 billion by 2034.
Key Highlights
• Drivers: Rising prevalence of Parkinson's disease, growing recognition of non-motor symptoms, and expanding adoption of targeted antipsychotic therapies.
• Challenges: High treatment costs, side effects of available therapies, and limited treatment options approved specifically for PDP.
• Leading Players: Acadia Pharmaceuticals, UCB Pharma, Novartis AG, Teva Pharmaceutical Industries, Johnson & Johnson (Janssen), Pfizer Inc., Lundbeck A/S, Sunovion Pharmaceuticals, AbbVie Inc., and Otsuka Holdings.
Segmentation Analysis
By Product
• Atypical Antipsychotics
o Pimavanserin (selective serotonin inverse agonist)
o Clozapine
o Quetiapine
• Adjunctive Therapies
o Cholinesterase Inhibitors
o Dopamine Modulators
• Supportive & Emerging Therapies
o Cognitive Behavioral Therapy (CBT)
o Digital Cognitive Support Tools
By Platform
• Prescription Medications
• Digital Health Platforms & Therapy Apps
• Combination Approaches
By Technology
• Serotonin Receptor-Targeted Therapies
• Dopamine-Sparing Antipsychotics
• Advanced Drug Delivery Systems (extended-release, targeted CNS delivery)
• AI-enabled Monitoring Tools
By End Use
• Hospitals
• Specialty Neurology & Psychiatry Clinics
• Ambulatory Care Centers
• Homecare & Telehealth Platforms
By Application
• Early PDP (mild hallucinations/delusions)
• Moderate to Severe PDP (advanced non-motor symptoms)
Segmentation Summary
Prescription atypical antipsychotics dominate the PDP market, with pimavanserin setting a new benchmark as the first FDA-approved therapy specifically for PDP. Quetiapine and clozapine are also used off-label. Digital health platforms are emerging as supportive tools, offering remote monitoring and non-pharmacological symptom management.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/71916/parkinson-s-disease-psychosis-market
Regional Analysis
North America
• Largest market share, driven by advanced healthcare infrastructure, high PD prevalence, and strong uptake of pimavanserin.
• The U.S. leads with robust reimbursement frameworks and extensive clinical trial activity.
Europe
• Strong market supported by national healthcare systems and government-backed Parkinson's initiatives.
• Germany, France, and the U.K. lead regional demand.
Asia-Pacific
• Fastest-growing region due to rising elderly populations, increased PD prevalence, and expanding healthcare investments.
• Japan has a high patient base, while China and India represent emerging growth markets for affordable therapies.
Middle East & Africa
• Gradual improvements in PD management, though access to advanced PDP treatments remains limited.
• GCC countries show higher adoption of innovative therapies compared to Sub-Saharan Africa.
Latin America
• Brazil and Mexico dominate regional growth, supported by improving access to neurology specialists and increased awareness of PD complications.
Regional Summary
North America and Europe remain the dominant markets, but Asia-Pacific is expected to post the fastest CAGR due to rapid demographic shifts, expanding healthcare access, and demand for cost-effective PDP management.
Market Dynamics
Key Growth Drivers
• Rising global prevalence of Parkinson's disease, particularly among aging populations.
• Increasing recognition and diagnosis of non-motor symptoms such as psychosis.
• Expanding use of pimavanserin and atypical antipsychotics tailored to PDP patients.
• Growing adoption of telehealth and digital monitoring platforms.
Key Challenges
• Limited approved therapies specifically for PDP.
• High treatment costs reducing affordability in low- and middle-income countries.
• Risk of adverse effects and drug interactions in elderly patients.
Latest Trends
• Expansion of serotonin-targeted therapies for PDP.
• Development of long-acting antipsychotic formulations for better adherence.
• Growing use of AI-based monitoring for cognitive and behavioral symptoms.
• Increasing collaborations between pharma companies and digital health providers.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71916
Competitor Analysis
Major Players
• Acadia Pharmaceuticals - Market leader with pimavanserin (Nuplazid).
• UCB Pharma - Active in neurology and psychiatry treatments.
• Novartis AG - Expanding presence in CNS therapeutics.
• Teva Pharmaceutical Industries - Strong in generics and neurology.
• Johnson & Johnson (Janssen) - Portfolio includes atypical antipsychotics.
• Pfizer Inc. - Active in CNS and psychiatric research.
• Lundbeck A/S - Specialist in psychiatric and neurological disorders.
• Sunovion Pharmaceuticals - Focused on CNS therapies.
• AbbVie Inc. - Strong in neurology and specialty pharmaceuticals.
• Otsuka Holdings - Expanding psychiatric and neurology portfolio.
Competitive Landscape Summary
The PDP market is moderately consolidated, with Acadia Pharmaceuticals leading through pimavanserin. Other pharmaceutical giants maintain strong presence via off-label use of atypical antipsychotics and pipeline therapies. Partnerships, R&D investment, and expansion into digital health will shape competition over the next decade.
Conclusion
The Parkinson's disease psychosis market is entering a phase of strong growth, driven by rising PD prevalence, greater awareness of non-motor symptoms, and innovation in targeted antipsychotic therapies. Despite challenges such as high costs and limited approvals, opportunities in digital health, long-acting drug delivery, and biosimilars ensure a positive outlook.
By 2034, the global PDP market is projected to reach USD 3.7 billion, underscoring its potential as a critical therapeutic area within neurology. Companies focusing on novel serotonin-targeted drugs, affordable generics, and patient-centered digital tools will be best positioned to lead this evolving market.
For patients and caregivers, this translates into improved quality of life, reduced caregiver burden, and greater access to specialized therapies over the coming decade.
This report is also available in the following languages : Japanese (パーキンソン病精神病市場), Korean (파킨슨병 정신병 시장), Chinese (帕金森病精神病市场), French (Marché des psychoses liées à la maladie de Parkinson), German (Markt für Parkinson-Psychose), and Italian (Mercato della psicosi del morbo di Parkinson), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/71916
Our More Reports:
EU5 Percutaneous Drainage Catheters Market
https://exactitudeconsultancy.com/reports/72344/eu5-percutaneous-drainage-catheters-market
North America Percutaneous Drainage Catheters Market
https://exactitudeconsultancy.com/reports/72343/north-america-percutaneous-drainage-catheters-market
Asia-Pacific Percutaneous Drainage Catheters Market
https://exactitudeconsultancy.com/reports/72342/asia-pacific-percutaneous-drainage-catheters-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Parkinson's Disease Psychosis (PDP) Market reaching approximately USD 3.7 billion by 2034 here
News-ID: 4179695 • Views: …
More Releases from Exactitude Consultancy
Parkinson's Disease Levodopa-Induced Dyskinesia (LID) Market New Product Develop …
Introduction
Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting movement, characterized by tremors, stiffness, and impaired coordination. Levodopa remains the gold standard for managing motor symptoms, but long-term use often results in levodopa-induced dyskinesia (LID) - a debilitating complication involving involuntary, erratic movements.
As patients live longer due to improved disease management, the incidence of LID continues to rise. The burden of dyskinesia not only reduces quality of life but also…
Peripheral Nerve Injuries Market reaching approximately USD 4.9 billion by 2034
Peripheral nerve injuries (PNIs) occur when nerves outside the brain and spinal cord are damaged, often leading to loss of motor function, sensory deficits, or chronic neuropathic pain. These injuries are commonly caused by trauma, surgery, repetitive stress, or medical conditions such as diabetes. Depending on severity, PNIs may involve partial or complete disruption of nerve fibers, significantly affecting patient quality of life.
The burden of PNIs is rising globally due…
Post-Traumatic Stress Disorder (PTSD) Market reaching approximately USD 13.4 bil …
Post-traumatic stress disorder (PTSD) is a psychiatric condition that develops after exposure to traumatic events such as combat, natural disasters, serious accidents, or violence. It manifests through symptoms like flashbacks, nightmares, heightened anxiety, and emotional numbness, often impairing daily functioning and quality of life. While once underdiagnosed and stigmatized, PTSD is increasingly recognized as a major public health concern worldwide.
The growing prevalence of PTSD among military veterans, first responders, survivors…
Neuromyelitis Optica Market Detailed Industry Report Analysis 2025-2034
Introduction
Neuromyelitis optica (NMO), also known as Devic's disease, is a rare autoimmune disorder of the central nervous system characterized by severe inflammation of the optic nerves and spinal cord. Patients often experience vision loss, paralysis, sensory impairment, and bladder dysfunction. Once considered a variant of multiple sclerosis (MS), NMO is now recognized as a distinct condition, thanks to advancements in diagnostics such as aquaporin-4 (AQP4) antibody testing.
Though rare, NMO can…
More Releases for PDP
Plasma Display Panel (PDP) Market to Witness Huge Growth by 2027 | Panasonic (Ja …
To continue with the reviews and details provided in this innovative Plasma Display Panel (PDP) market report, it also aims at providing advanced data concerning to Plasma Display Panel (PDP) market global status, market trends analysis, segment, size, growth, share and forecast from 2021 to 2027. The information generated in this Market Report is based on news, information insiders, primary research and interviews with top supervisors. Some secondary research…
Gaming Headset Market 2019 Global Analysis By Key Players – Turtle Beach, Sony …
Gaming Headset Market 2019
Wiseguyreports.Com adds “Gaming Headset Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.
Report Details:
This report provides in depth study of “Gaming Headset Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Gaming Headset Market report also provides an in-depth survey of key players in the market which is based on the various objectives…
PDP Flat Panel Display Market Share, Industry Size, Growth, Opportunities, and M …
The Global PDP Flat Panel Display Market Research Report 2017 renders deep perception of the key regional market status of the Proteomics Reagents Industry on a global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, China and Japan.
The report on Global PDP Flat Panel Display Market is a professional report which provides…
Global PDP Flat Panel Display Market Analysis & Forecast Report 2017-2022
Summary
The Global PDP Flat Panel Display Market Analysis & Forecast Report 2017-2022 is a professional and in-depth study on the current state of the PDP Flat Panel Display Market. The report analysis the global market of PDP Flat Panel Display by main manufactures and geographic regions. The report includes PDP Flat Panel Display definitions, classifications, applications and industry chain structure, development trends, competitive landscape analysis, and key regions development and…
Global PDP Flat Panel Display Market Professional Survey Report 2016
This report studies PDP Flat Panel Display in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Panasonic Corporation
Sony Corporation
LG Display Co. Ltd.
Samsung Electronics Co. Ltd.
Emerging Display Technologies Corp
NEC
Pioneer Electronics
Hitachi
Fujitsu
HORIBA,…
PDP TV Sales Market 2017 Global Share, Trends, Opportunities & Forecast
Consistent with our stated policy of making available the best research material from across the globe to our ever-growing list of erudite clients, here is another report that is sure to meet their high expectations. This 2017 market research report on Global PDP TV Sales Market is a meticulously undertaken study. Experts with proven credentials and a high standing within the research fraternity have presented an in-depth analysis of the…
